RA CAPITAL MANAGEMENT, L.P. Q4 2016 Filing
Filed February 14, 2017
Portfolio Value
$684.7B
Holdings
26
Report Date
Q4 2016
Filing Type
13F-HR
All Holdings (26 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | WVEWAVE LIFE SCIENCES LTD | 7,088,651 | $185.4B | 27.07% | |
| 2 | ASNDASCENDIS PHARMA A S | 5,409,990 | $109.5B | 15.99% | |
| 3 | —AVEXIS INC | 1,890,796 | $90.2B | 13.18% | |
| 4 | —ACHILLION PHARMACEUTICALS INC | 13,633,220 | $56.3B | 8.22% | |
| 5 | —AQUINOX PHARMACEUTICALS INC | 2,191,977 | $36.2B | 5.29% | |
| 6 | —ZOGENIX INC | 2,451,237 | $29.8B | 4.35% | |
| 7 | ARDXARDELYX INC | 1,935,305 | $27.5B | 4.01% | |
| 8 | —FOAMIX PHARMACEUTICALS LTD | 1,820,138 | $20.2B | 2.95% | |
| 9 | BCRXBIOCRYST PHARMACEUTICALS | 2,989,795 | $18.9B | 2.76% | |
| 10 | —RA PHARMACEUTICALS INC | 1,190,270 | $18.1B | 2.64% | |
| 11 | PTGXPROTAGONIST THERAPEUTICS INC | 692,563 | $14.6B | 2.14% | |
| 12 | —AIMMUNE THERAPEUTICS INC | 677,663 | $13.9B | 2.02% | |
| 13 | —AUDENTES THERAPEUTICS INC | 532,426 | $9.7B | 1.42% | |
| 14 | ONCBEIGENE LTD | 240,000 | $7.3B | 1.06% | |
| 15 | —DICERNA PHARMACEUTICALS INC | 2,428,571 | $7.0B | 1.02% | |
| 16 | —ABEONA THERAPEUTICS INC | 1,142,857 | $5.5B | 0.81% | |
| 17 | —STRONGBRIDGE BIOPHARMA PLC | 2,279,099 | $5.5B | 0.80% | |
| 18 | TGTXTG THERAPEUTICS INC | 1,004,314 | $4.7B | 0.68% | |
| 19 | —TENAX THERAPEUTICS INC | 2,389,700 | $4.7B | 0.68% | |
| 20 | KALVKALVISTA PHARMACEUTICALS INC | 591,070 | $4.2B | 0.61% | |
| 21 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 354,200 | $4.1B | 0.60% | |
| 22 | —DIMENSION THERAPEUTICS INC | 928,199 | $4.0B | 0.59% | |
| 23 | —IDERA PHARMACEUTICALS INC | 2,250,000 | $3.4B | 0.49% | |
| 24 | —MEDICINES CO | 79,899 | $2.7B | 0.40% | |
| 25 | —AKARI THERAPEUTICS PLC | 101,439 | $714.0M | 0.10% | |
| 26 | —ARCA BIOPHARMA INC | 232,245 | $662.0M | 0.10% |